KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EBIT (2016 - 2019)

National Health Investors filings provide 11 years of EBIT readings, the most recent being $42.8 million for Q3 2019.

  • On a quarterly basis, EBIT rose 4.33% to $42.8 million in Q3 2019 year-over-year; TTM through Sep 2019 was $159.4 million, a 1.15% increase, with the full-year FY2019 number at $217.6 million, up 6.59% from a year prior.
  • EBIT hit $42.8 million in Q3 2019 for National Health Investors, up from $40.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $46.4 million in Q4 2016 to a low of $18.6 million in Q2 2016.
  • Median EBIT over the past 5 years was $39.2 million (2018), compared with a mean of $37.8 million.
  • Biggest five-year swings in EBIT: tumbled 54.63% in 2016 and later surged 106.13% in 2017.
  • National Health Investors' EBIT stood at $42.1 million in 2015, then increased by 10.22% to $46.4 million in 2016, then fell by 14.64% to $39.6 million in 2017, then rose by 3.52% to $41.0 million in 2018, then increased by 4.33% to $42.8 million in 2019.
  • The last three reported values for EBIT were $42.8 million (Q3 2019), $40.0 million (Q2 2019), and $35.7 million (Q1 2019) per Business Quant data.